Currently in the US all invasive breast tumors need to have ER/PR/Her2 stain results for the choice of treatment and prognosis. For some hospitals, if the tumors are triple negative, EGFR, CK5 (or CK5/6), CK14, CK17 stains will be performed to see if it is a basal-like ca. In fact there is no difference in clinical treatment of basal-like ca with others. we just call invasive ductal carcinoma with basal-like phonotype.
以下是引用wfbjwt在2010-1-7 20:10:00的发言:
请教:1、要不要考虑基底细胞样癌?2、EGFR标记有什么作用?
Currently in the US all invasive breast tumors need to have ER/PR/Her2 stain results for the choice of treatment and prognosis. For some hospitals, if the tumors are triple negative, EGFR, CK5 (or CK5/6), CK14, CK17 stains will be performed to see if it is a basal-like ca. In fact there is no difference in clinical treatment of basal-like ca with others. we just call invasive ductal carcinoma with basal-like phonotype.